Levi Strauss maintained its full-year 2025 guidance, projecting adjusted earnings per share of $1.20 to $1.25. This outlook ...
Investing.com -- U.S. President Donald Trump continues to press forward with his tariff policy despite widespread carnage in ...
In the memo, Lutke described Shopify as a company that must continue to grow and improve year over year, in line with its ...
In China, sentiment in equity markets has rebounded, but macro data has remained mixed. BofA’s China economics team held its ...
Poilievre has criticized the current government’s policies, which he believes have led to Canada’s economic decline, and has ...
Reddit is rapidly growing social media platforms, with a compelling combination of user engagement, under-monetized assets, ...
The Cboe Volatility Index, an options-based measure of investor anxiety often referred to as Wall Street’s ’fear gauge’, ...
Investing.com -- Nvidia’s AI server products are likely exempt from the latest round of U.S. tariffs under the ...
BofA’s quantitative signals indicate a mixed near-term outlook for the USD. After gaining more than 1% last week, the CARS ...
The Liberal Party of Canada, led by Prime Minister Mark Carney, announced a set of measures on Monday aimed at providing ...
Dalio also touches on the breakdown of the domestic political order in the U.S., characterized by deep divisions in education, opportunity, productivity, income, wealth, and values. He notes that the ...
Shares of Pacira BioSciences, Inc. (NASDAQ: PCRX) leaped 15% following the announcement of a settlement in U.S. patent litigation concerning its flagship product, EXPAREL. The agreement effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results